Emilia Romagna (ITH5)
Population per km² (2017) : 201
Innovation Performance Group (2019) : Moderate +
Emilia-Romagna is a region in the northeast of Italy comprising the historical regions of Emilia and Romagna, it has a population of 4.5 million. It is home to the University of Bologna, which was founded in 1088 and is the oldest university in the world.
The region has a focus on the emerging fields of regenerative and restorative medicine, as well as pharmaceutical and omics sciences and inclusive services and usable technologies for healthy living and active aging.
Emilia-Romagna is involved in a number of major initiatives in the field of personalised medicine including Hologene, Custom Implants, Italian Infrastructure for Regenerative Medicine, SUPER HPC and Big Data and Italian Biobanks network.
Is the region looking for international/European/interregional collaboration opportunities?
Yes - Identification of standard protocols to collect data and support on how to overcome the barriers about privacy regulation
National level: SNSI - National smart specialization
National level: ALISEI applied life science national cluster strategic plan
Topics covered by policies : Medical research and innovation (-omics, biomarkers, diagnostics, etc.); Specific disease related research;Prediction and prevention; ICT/genomics, health, lifestyle data(infrastructure); Electronic and mobile health solutions; Public awareness, patient participation with respect to Personalised Medicine/Personalised Health
Policy document (RIS3): Yes
Policy document PM@RIS3: Yes
Hologene 7 2.0
SUPER HPC and Big Data
BBMRI.it Italian Biobanks network
Collaboration with Piedmont Region
BIOGEN - Genetic Biobank
LTTA Biobank (Laboratory for Advanced Therapy Technologies)
Digital Innovation Hubs:
SMILE-DIH (Smart Manufacturing Innovation for Lean Excellence center - Digital Innovation Hub)
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
BBMRI EUS3 Platform - Personalized Medicine
H2020 - SMEINST - Oncosmart - ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics
H2020- SMEINST- BIOFOSTE - Clinical validation of a BIOmarker panel For OSTEoarthritis diagnosis: BIOFOSTE
H2020 - SC1- ADIPOA2 - Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis
By TUBS - Own workThis SVG map includes elements that have been taken or adapted from this map: Italy location map.svg (by NordNordWest)., CC BY-SA 3.0,